Brandi L. Roberts
Net Worth

Last updated:

What is Brandi L. Roberts net worth?

The estimated net worth of Ms. Brandi L. Roberts is at least $2,450,950 as of 13 Aug 2019. She owns shares worth $6,250 as insider and has received compensation worth at least $2,444,700 in Lineage Cell Therapeutics, Inc..

What is the salary of Brandi L. Roberts?

Ms. Brandi L. Roberts salary is $407,450 per year as Consultant in Lineage Cell Therapeutics, Inc..

How old is Brandi L. Roberts?

Ms. Brandi L. Roberts is 51 years old, born in 1974.

What stocks does Brandi L. Roberts currently own?

As insider, Ms. Brandi L. Roberts owns shares in one company:

Company Title Shares Price per share Total value
Lineage Cell Therapeutics, Inc. (LCTX) Consultant 5,000 $1.25 $6,250

What does Lineage Cell Therapeutics, Inc. do?

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also offers Renevia, a facial aesthetics product. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

Brandi L. Roberts insider trading

Lineage Cell Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Shares 5,000 $1.01 $5,050

Lineage Cell Therapeutics key executives

Lineage Cell Therapeutics, Inc. executives and other stock owners filed with the SEC:

  • Mr. Brian M. Culley M.A., M.B.A. (54) Chief Executive Officer, Pres & Director
  • Ms. Brandi L. Roberts (51) Consultant